RESUMO
Little is known about mite gait, but it has been suggested that there could be greater variation in locomotory styles for arachnids than insects. The Varroa destructor mite is a devastating ectoparasite of the honeybee. We aim to automatically detect Varroa-specific signals in long-term vibrational recordings of honeybee hives and additionally provide the first quantification and characterisation of Varroa gait through the analysis of its unique vibrational trace. These vibrations are used as part of a novel approach to achieve remote, non-invasive Varroa monitoring in honeybee colonies, requiring discrimination between mite and honeybee signals. We measure the vibrations occurring in samples of freshly collected capped brood-comb, and through combined critical listening and video recordings we build a training database for discrimination and classification purposes. In searching for a suitable vibrational feature, we demonstrate the outstanding value of two-dimensional-Fourier-transforms in invertebrate vibration analysis. Discrimination was less reliable when testing datasets comprising of Varroa within capped brood-cells, where Varroa induced signals are weaker than those produced on the cell surface. We here advance knowledge of Varroa vibration and locomotion, whilst expanding upon the remote detection strategies available for its control.
Assuntos
Varroidae , Animais , Abelhas , Vibração , Marcha , Aprendizado de MáquinaRESUMO
Older people constitute the majority of high-risk surgical patients. Despite this, they are often excluded from patient and public involvement and engagement (PPIE) and research in the perioperative setting. Comprehensive Geriatric Assessment (CGA)-based perioperative services demonstrate clinical and cost effectiveness for older patients but are not delivered at all hospitals. Scaling up such services across the NHS requires PPIE to deliver quality, patient-centred care with fidelity to existing evidence. We describe the process of, and outputs from, PPIE in older patients to inform future implementation and evaluation of CGA-based perioperative services at scale. Results show older patients value CGA-based perioperative care and support widespread implementation to deliver streamlined perioperative care, coordinated specialist input and clear communication between clinicians and with patients. This case study illustrates how to champion the voice of older people to develop pathways of care aligned to needs of service users.
RESUMO
BACKGROUND: Hypoadrenocorticism is an important differential for hypercalcemia. The etiology of hypercalcemia in hypoadrenocorticism in dogs is unclear. OBJECTIVE: To review the prevalence of hypercalcemia and use statistical models to identify clinical, demographic, and biochemical variables associated with hypercalcemia in dogs with primary hypoadrenocorticism. ANIMALS: One hundred ten dogs with primary hypoadrenocorticism; 107 with recorded total calcium (TCa), 43 recorded ionized calcium (iCa). METHODS: Multicenter retrospective observational study at 4 UK referral hospitals. Univariable logistic regression analyses were performed to assess the association between independent variables of signalment, hypoadrenocorticism type (glucocorticoid only deficient hypoadrenocorticism [GHoC] vs glucocorticoid and mineralocorticoid deficient hypoadrenocorticism [GMHoC]), clinicopathological variables and hypercalcemia. Hypercalcemia was defined as elevated TCa, an elevated iCa, or both elevated TCa and iCa (Model 1) or as elevated iCa (Model 2). RESULTS: Overall prevalence of hypercalcemia was 34.5% (38/110). The odds of hypercalcemia (Model 1) were increased (P < .05) in dogs with GMHoC ([vs GHoC], OR [odds ratio] = 3.86, 95% confidence interval [CI] 1.105-13.463), higher serum creatinine (OR = 1.512, 95% CI 1.041-2.197), and higher serum albumin (OR = 4.187, 95% CI 1.744-10.048). The odds of ionized hypercalcemia (Model 2) were increased (P < .05) with reduced serum potassium concentration (OR = 0.401, 95% CI 0.184-0.876) and younger age (OR = 0.737, 95% CI 0.558-0.974). CONCLUSIONS AND CLINICAL IMPORTANCE: This study identified several key clinical and biochemical variables associated with hypercalcemia in dogs with primary hypoadrenocorticism. These findings aid understanding of the pathophysiology and etiology of hypercalcemia in dogs with primary hypoadrenocorticism.
Assuntos
Insuficiência Adrenal , Doenças do Cão , Hipercalcemia , Cães , Animais , Hipercalcemia/epidemiologia , Hipercalcemia/veterinária , Cálcio , Estudos Retrospectivos , Glucocorticoides , Prevalência , Doenças do Cão/epidemiologia , Insuficiência Adrenal/veterináriaRESUMO
Case summary: A 5-year-old female neutered domestic mediumhair cat presented with acute onset hyporexia, lethargy, ascites, hypoalbuminaemia and ventral subcutaneous oedema. Further investigations revealed a bicavitary effusion, myocardial injury, hypercholesterolaemia and concurrent marked proteinuria. A panel of infectious disease tests yielded negative results. Nephrotic syndrome was suspected and renal biopsies were performed. Histopathology and electron microscopy confirmed a diagnosis of minimal change disease (MCD). The patient was successfully managed with benazepril, clopidogrel and a veterinary prescription renal diet. Follow-up two weeks later documented almost complete resolution of the cardiac abnormalities, absence of clinical signs and marked improvement in clinicopathological findings. The hypoalbuminaemia and proteinuria had resolved two months after presentation. At the time of writing, 13 months post-admission, the cat remained asymptomatic with no evidence of disease relapse. Relevance and novel information: MCD is rarely described in the veterinary literature, with only four cases reported to date. To our knowledge, this report describes the first case of successfully treated MCD-associated nephrotic syndrome in a cat without the use of glucocorticoid treatment.
RESUMO
An 11 year old female-neutered Labrador presented for facial swelling. Clinicopathological abnormalities included hyperglobulinemia, azotemia, hypercalcemia, nonregenerative anemia, thrombocytopenia, and spurious hypoglycemia. Normoglycemia was subsequently confirmed using a cage-side analyzer (AlphaTRAK, Zoetis, UK). Serum and urine protein electrophoresis documented monoclonal (immunoglobulin M) gammopathy with Bence-Jones proteinuria. Computed tomography imaging revealed a monostotic osteolytic bone-lesion, and bone marrow cytology and histopathology documented plasmacytosis with multiple myeloma oncogene 1 / interferon regulatory factor 4 positivity, consistent with multiple myeloma. Infectious disease testing initially indicated seropositivity for Leishmania, Borrelia, and Anaplasma spp.; however, Leishmania PCR (splenic and bone marrow aspirates), and paired serological titers for Borrelia and Anaplasma were negative. Consequently, initial serological results were considered to be false positive because of paraproteinemia-associated assay interference. Chemotherapy (prednisolone and melphalan combination therapy) was initiated, but the dog was euthanased 30 days later because of the development of pericardial effusion. This is a report of spurious serological (and other laboratory) results occurring secondary to monoclonal gammopathy in a dog.
Assuntos
Doenças do Cão , Mieloma Múltiplo , Proteinúria , Feminino , Cães , Animais , Mieloma Múltiplo/complicações , Mieloma Múltiplo/diagnóstico , Mieloma Múltiplo/veterinária , Imunoglobulina M/uso terapêutico , Melfalan/uso terapêutico , Medula Óssea/patologia , Proteinúria/tratamento farmacológico , Proteinúria/veterinária , Doenças do Cão/diagnóstico , Doenças do Cão/tratamento farmacológicoAssuntos
Conhecimento , Ciência , Transtorno Autístico/etiologia , Evolução Biológica , Mudança Climática , Consenso , Exobiologia , Homeopatia , Humanos , Política , VacinasRESUMO
OBJECTIVES: To determine whether veterinarians in primary care practices (PCPs) and board-certified clinicians (BCCs) approach treatment of dogs with immune-mediated haemolytic anaemia (IMHA) similarly, and whether practitioners with more experience treat similarly to those with less experience. We hypothesised those in PCPs would show more variation in their approach to similar cases than BCCs. METHODS: A cross-sectional study was conducted by distributing a questionnaire to BCCs and veterinarians in PCPs. The questionnaire included direct questions and a number of clinical scenarios intended to capture approaches to common treatment problems. RESULTS: Questionnaire responses were received from 241 veterinarians, including 216 in PCPs and 25 BCCs. Veterinarians in both settings used similar tests for diagnosis of IMHA, but BCCs performed more tests to exclude underlying causes of 'associative' disease. All veterinarians reported use of similar initial dosages of glucocorticoids (median 2 mg/kg per day in both groups, p = 0.92) but those used by more experienced practitioners were higher than those with less experience. Most veterinarians made allowances for the weight of dogs, using lower prednisolone dosages in a clinical scenario involving a 40 kg dog compared to a 9 kg dog (p = 0.025 for PCP, p = 0.002 for BCC). BCCs reported greater use of combinations of immunosuppressive drugs (p<0.0001) and of antithrombotic drugs (p<0.0001); use of antithrombotic drugs was also less common among more experienced practitioners compared to less experienced. CONCLUSIONS: Approaches to treatment of dogs with IMHA differ between BCCs and those in PCP. These differences may affect design and implementation of future research studies and clinical guidelines.